Notice for pretomanid (Alphapharm Pty Ltd)
Active ingredients
pretomanid
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet
Indication
Indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (XDR), or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB)
Therapeutic area
Infectious diseases